ConCallIQ
Go Pro
GODREJCP Diversified 23 Oct 2024

Godrej Consumer Products Limited — Q2 FY25

GCPL reported a steady quarter with India standalone volume growth of 7% and value growth of 7%, but EBITDA was flat due to high palm oil inflation.

neutral medium
Compare with...
Revenue ₹3,666 Cr
EBITDA
PAT ₹491 Cr
EBITDA Margin
Duration
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

GCPL reported a steady quarter with India standalone volume growth of 7% and value growth of 7%, but EBITDA was flat due to high palm oil inflation. The company maintained A&P spend at 11.6% despite margin pressure, emphasizing quality over cost-cutting. International markets showed mixed performance: Indonesia delivered 7% volume growth and 17% EBITDA growth, while GAUM saw organic volume decline of 8% but EBITDA grew 33% as margins improved to 14.5%. LatAm rebounded strongly with 50% UVG and double-digit EBITDA margins. Management highlighted green shoots from the RNF molecule relaunch in HI, particularly in coils and incense sticks, but cautioned that electrics may take another quarter. Key risks include sustained palm oil inflation, urban GT slowdown, and competitive pressure in soaps from structuring technologies. The company expects volume growth to remain range-bound near high single digits for the next couple of quarters.

Promises0 met · 1 missedRisks4 trackedTranscriptfull text
Research workspace

Focused Modules

Promises 1 promise

Promise Tracker

0 delivered, 0 close, 1 missed.

View Promises →
!Risks 4 risks

Risk Intelligence

Palm oil inflation and import duty impact

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

India standalone volume growth 7%
flat YoY

India business grew 7% volume and 7% value, with EBITDA flat due to palm oil inflation.

Indonesia EBITDA growth 17%
+17% YoY

Indonesia delivered 7% volume growth and 17% EBITDA growth, driven by core categories.

GAUM EBITDA growth 33%
+33% YoY

GAUM organic volumes declined 8% but EBITDA grew 33%, with margins improving to 14.5%.

LatAm UVG 50%
+50% YoY

LatAm business performed well with 50% underlying volume growth and double-digit EBITDA margins.

What Changed vs Last Quarter

Comparing Q2 FY25 vs Q1 FY25
4 new guidance4 dropped4 new risk4 risk resolved
NEW
India EBITDA margin to remain in 24-25% range for next two quarters

Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investments.

NEW
RCCL EBITDA may fall short of 145-150 crore target

The Raymond consumer portfolio EBITDA may be slightly below the promised 145-150 crore for the year due to distribution missteps in urban general trade.

NEW
HI category to aim for high single-digit volume growth

Management targets high single-digit volume growth for household insecticides, driven by RNF molecule rollout and distribution expansion.

NEW
Africa margins to improve to high teens over next year or two

Africa EBITDA margins are expected to reach high teens, driven by supply chain efficiencies and stable macro conditions.

DROPPED
India pricing to turn positive from Q2 FY25

Management expects pricing to become positive sequentially from Q2, with full-year pricing growth of 2-3%.

DROPPED
India volume growth target of low double-digit for FY25

Management aims for low double-digit volume growth in India for the full year, implying acceleration from 8% in Q1.

DROPPED
Raymond business EBITDA to be 15-20% below target of INR 160 crore

Raymond acquisition EBITDA for FY25 is expected to be 15-20% below the original target of INR 160 crore, but significantly higher than the inherited INR 60 crore.

DROPPED
Pet care subsidiary to be cash positive in five years

Godrej Pet Care is expected to become cash positive after five years, with manufacturing commencing in H2 FY26.

NEW RISK
Palm oil inflation and import duty impact

Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.

NEW RISK
Urban general trade slowdown

Urban general trade is under pressure from quick commerce disruption and consumption slowdown, which could impact distribution and sales.

NEW RISK
RCCL EBITDA target miss

Raymond consumer portfolio may miss the 145-150 crore EBITDA target due to distribution issues in urban GT, though management expects only a slight shortfall.

NEW RISK
Competitive pressure from soap structuring

Market leader's adoption of bathing bar technology could widen price gap, though management believes quality focus will protect market share.

RISK GONE
Currency volatility in Africa impacting revenue

Extreme currency fluctuations in Nigeria and Ghana led to distributor destocking and a 21% volume decline in GAUM. High interest rates may prolong the destocking.

RISK GONE
Palm oil price headwind for India margins

Sharp increase in palm oil prices pressured India EBITDA margins in Q1, and management noted it as a headwind for the year.

RISK GONE
Raymond urban GT distribution misstep

Integration of urban general trade distribution led to market share loss in deodorants. Management is reverting to a specialized channel, which may delay profit targets.

RISK GONE
Pet care investment may not yield expected returns

The INR 500 crore investment in pet care is a long-term bet with uncertain returns. Management acknowledged EBITDA margins may be lower than HPC.

🤫 Topics management stopped discussing

Steady improvement in EBITDA margins

Mentioned in Q2 FY24, Q3 FY24

Management anticipates steady improvement in EBITDA margins through structural cost reduction actions.

Fast read

Guidance and risk preview

Top guidance India EBITDA margin to remain in 24-25% range for next two quarters

Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investme...

Top risk Palm oil inflation and import duty impact

Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.

View Risks →